Work

Endogenous Iron(II) Self-Enriched Fenton Nanocatalyst via FTH1 Activity Inhibition and Iron(III) Reduction for Amplified Cancer Ferroptosis Therapy

Year: 2025

Type: article

Source: Molecular Pharmaceutics

DOI: 10.1021/acs.molpharmaceut.4c01292

Authors: Ying Chen, Qin Ma, Jun Zhang, Jianhang Li, Yu’e Wang, Yongchao Yao, Yang Ding, Xin Dai, Xinghong Luo, Linjing Wu, Ling Tao, Xiangchun Shen

Institutions: Guiyang Medical University, China Pharmaceutical University, State Key Laboratory of Natural Medicine, Zunyi Medical and Pharmaceutical College

Language: English

Topic: Nanoplatforms for cancer theranostics

Subfield: Biomedical Engineering

Field: Engineering

Domain: Physical Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Natural Science Foundation of China

Award: G7080597755

OpenAlex ID: W4407231982

FWCI: 1.895

Cites: 36

Cited by: 8

Related to: 10